First Manhattan CO Roivant Sciences Ltd. Transaction History
First Manhattan CO
- $29.6 Billion
- Q1 2024
A detailed history of First Manhattan CO transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, First Manhattan CO holds 11,400 shares of ROIV stock, worth $119,472. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,400
Previous 11,000
3.64%
Holding current value
$119,472
Previous $123,000
2.44%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ROIV
# of Institutions
263Shares Held
489MCall Options Held
565KPut Options Held
1.68M-
Sb Investment Advisers (Uk) LTD London, X073MShares$765 Million7.6% of portfolio
-
Viking Global Investors LP69.4MShares$727 Million2.78% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$699 Million65.04% of portfolio
-
Black Rock Inc. New York, NY36.2MShares$379 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.6MShares$373 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.38B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...